Search

Your search keyword '"D’Arminio Monforte, A."' showing total 3,264 results

Search Constraints

Start Over You searched for: Author "D’Arminio Monforte, A." Remove constraint Author: "D’Arminio Monforte, A."
3,264 results on '"D’Arminio Monforte, A."'

Search Results

101. A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy

102. Chest pain and a left parasternal soft tissue swelling in an immunocompetent refugee with disseminated tuberculosis

103. Influence of efavirenz and 8‐hydroxy‐efavirenz plasma levels on cognition and central nervous system side effects.

104. Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts.

105. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

106. Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort

107. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

108. Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

109. Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

110. Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

112. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

115. Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes

116. The Many Faces of Covid-19 at a Glance: A University Hospital Multidisciplinary Account From Milan, Italy

117. Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients

118. Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19

119. Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study

120. The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons

121. A first update on mapping the human genetic architecture of COVID-19

124. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness

125. Ability to Monitor National Responses to the HIV Epidemic 'Beyond Viral Suppression': Findings From Six European Countries

126. Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.

127. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

128. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

129. Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature

130. Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective Analysis

132. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

135. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

136. Resilience, Psychological Well-Being and Daily Functioning Following Hospitalization for Respiratory Distress Due to SARS-CoV-2 Infection

137. Declining Mortality Rate of Hospitalised Patients in the Second Wave of the COVID-19 Epidemics in Italy: Risk Factors and the Age-Specific Patterns

138. Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study

139. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies

140. The effect of switching to Maraviroc + Darunavir/ritonavir dual therapy in virologically suppressed patients on the progression of liver fibrosis: findings from a randomized study

141. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

142. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection

143. Whole-genome sequencing reveals host factors underlying critical COVID-19

144. An explainable model of host genetic interactions linked to COVID-19 severity

145. Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study

146. Incidence, Risk Factors and Impact on Clinical Outcomes of Bloodstream Infections in Patients Hospitalised with COVID-19: A Prospective Cohort Study

147. Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study

148. Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV

149. Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study

150. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV

Catalog

Books, media, physical & digital resources